| Primary |
| Product Used For Unknown Indication |
49.2% |
| Cough |
17.0% |
| Respiratory Tract Congestion |
9.9% |
| Nasopharyngitis |
4.8% |
| Blood Pressure |
2.1% |
| Hypertension |
2.1% |
| Drug Abuse |
1.8% |
| Increased Upper Airway Secretion |
1.6% |
| Nasal Congestion |
1.6% |
| Malaise |
1.4% |
| Bronchitis |
1.1% |
| Sinus Congestion |
1.1% |
| Upper Respiratory Tract Infection |
1.1% |
| Anxiety |
0.9% |
| Back Pain |
0.7% |
| Blood Cholesterol |
0.7% |
| Chest Discomfort |
0.7% |
| Hormone Replacement Therapy |
0.7% |
| Hypersensitivity |
0.7% |
| Sinus Disorder |
0.7% |
|
| Blood Pressure Increased |
11.7% |
| Epistaxis |
10.2% |
| Vomiting |
10.2% |
| Dizziness |
6.7% |
| Hallucination |
5.7% |
| Somnolence |
5.7% |
| Headache |
4.9% |
| Loss Of Consciousness |
4.6% |
| Nausea |
4.6% |
| Haemoptysis |
4.2% |
| Feeling Abnormal |
3.9% |
| Incorrect Drug Administration Duration |
3.9% |
| Hypertension |
3.5% |
| Syncope |
3.5% |
| Drug Abuse |
3.2% |
| Palpitations |
3.2% |
| Dyspnoea |
2.8% |
| Wrong Technique In Drug Usage Process |
2.8% |
| Tachycardia |
2.5% |
| Diarrhoea |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
26.5% |
| Cough |
17.7% |
| Respiratory Tract Congestion |
13.5% |
| Chronic Obstructive Pulmonary Disease |
5.6% |
| Nasopharyngitis |
5.6% |
| Drug Use For Unknown Indication |
3.7% |
| Allergy To Chemicals |
2.8% |
| Dizziness |
2.8% |
| Malaise |
2.8% |
| Bronchitis |
2.3% |
| Multiple Allergies |
2.3% |
| Nasal Congestion |
2.3% |
| Hypertension |
1.9% |
| Productive Cough |
1.9% |
| Respiratory Tract Infection |
1.9% |
| Vasomotor Rhinitis |
1.9% |
| Fatigue |
1.4% |
| Headache |
1.4% |
| Asthma |
0.9% |
| Back Pain |
0.9% |
|
| Epistaxis |
11.4% |
| Syncope |
10.0% |
| Drug Abuse |
7.1% |
| Vomiting |
7.1% |
| Blood Pressure Increased |
5.7% |
| Convulsion |
4.3% |
| Dizziness |
4.3% |
| Faeces Discoloured |
4.3% |
| Headache |
4.3% |
| Incorrect Drug Administration Duration |
4.3% |
| Loss Of Consciousness |
4.3% |
| Nausea |
4.3% |
| Palpitations |
4.3% |
| Respiratory Tract Infection |
4.3% |
| Speech Disorder |
4.3% |
| Wheezing |
4.3% |
| Blood Glucose Decreased |
2.9% |
| Confusional State |
2.9% |
| Diarrhoea |
2.9% |
| Feeling Abnormal |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.8% |
| Product Used For Unknown Indication |
16.1% |
| Chronic Obstructive Pulmonary Disease |
8.2% |
| Asthma |
7.7% |
| Pain |
7.5% |
| Metastases To Bone |
5.8% |
| Cough |
4.6% |
| Hypertension |
3.8% |
| Contraception |
3.4% |
| Hypersensitivity |
2.7% |
| Immune System Disorder |
2.7% |
| Constipation |
2.6% |
| Nausea |
2.6% |
| Depression |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Supplementation Therapy |
2.2% |
| Bronchitis |
2.1% |
| Crohn's Disease |
1.9% |
| Diabetes Mellitus |
1.9% |
| Premenstrual Syndrome |
1.9% |
|
| Pneumonia |
11.1% |
| Death |
8.6% |
| White Blood Cell Count |
7.4% |
| Drug Ineffective |
6.2% |
| Diarrhoea |
4.9% |
| Dyspnoea |
4.9% |
| Lung Neoplasm Malignant |
4.9% |
| Pain |
4.9% |
| Pulmonary Embolism |
4.9% |
| Wheezing |
4.9% |
| Chest Pain |
3.7% |
| Dehydration |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Neoplasm Malignant |
3.7% |
| Nervousness |
3.7% |
| Product Quality Issue |
3.7% |
| Subcutaneous Abscess |
3.7% |
| Throat Irritation |
3.7% |
| Tricuspid Valve Incompetence |
3.7% |
| Vomiting |
3.7% |
|
| Interacting |
| Depression |
50.0% |
| Anxiety |
33.3% |
| Generalized Anxiety Disorder |
16.7% |
|
|
